2020 international consensus on ANCA testing beyond systemic vasculitis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
This document follows up on a 2017 revised international consensus on anti-neutrophil cytoplasm antibodies (ANCA) testing in granulomatosis with polyangiitis and microscopic polyangiitis and focuses on the clinical and diagnostic value of ANCA detection in patients with connective tissue diseases, idiopathic interstitial pneumonia, autoimmune liver diseases, inflammatory bowel diseases, anti-glomerular basement membrane (GBM) disease, infections, malignancy, and during drug treatment. Current evidence suggests that in certain settings beyond systemic vasculitis, ANCA may have clinical, pathogenic and/or diagnostic relevance. Antigen-specific ANCA targeting proteinase-3 and myeloperoxidase should be tested by solid phase immunoassays in any patient with clinical features suggesting ANCA-associated vasculitis and in all patients with anti-GBM disease, idiopathic interstitial pneumonia, and infective endocarditis associated with nephritis, whereas in patients with other aforementioned disorders routine ANCA testing is not recommended. Among patients with autoimmune liver diseases or inflammatory bowel diseases, ANCA testing may be justified in patients with suspected autoimmune hepatitis type 1 who do not have conventional autoantibodies or in case of diagnostic uncertainty to discriminate ulcerative colitis from Crohn's disease. In these cases, ANCA should be tested by indirect immunofluorescence as the target antigens are not yet well characterized. Many questions concerning the optimal use of ANCA testing in patients without ANCA-associated vasculitis remain to be answered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868 · cited 1×
“PSC can overlap with AIH in 5-10% of cases and is closely associated with inflammatory bowel disease, most often ulcerative colitis (UC) [70].”
BackgroundAutoantibodies in primary sclerosing cholangitis
Hov, J. R., Boberg, K. M., & Karlsen, T. H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3781 · Cited by 187 · cited 3×
“In several small studies (reviewed in [71]), the prevalence of atypical P-ANCA ranged from 26% to 94% (median of 63%).”
BackgroundInfluentialClinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases
Roozendaal, C., Jong, M. A. D., Berg, A. P. V. D., Wijk, R. T. V., Limburg, P. C., & Kallenberg, C. G. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80241-x · Cited by 100 · cited 1×
“The reported frequency of atypical P-ANCA in PBC ranged from 26% to 67% [66,68,69].”
BackgroundBalavoine, A.-S., Glinoer, D., Dubucquoi, S., & Wémeau, J.-L. (2015) · Thyroid® · doi:10.1089/thy.2014.0603 · Cited by 65
Gao, Y., Chen, M., Ye, H., Yu, F., Guo, X.-H., & Zhao, M.-H. (2008) · Rheumatology · doi:10.1093/rheumatology/ken321 · Cited by 64
Self-citationLenzen, H., Weismüller, T. J., Negm, A. A., Wlecke, J., Loges, S., Strassburg, C. P., Manns, M. P., & Lankisch, T. O. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.825313 · Cited by 11 · cited 1×
“001), and was associated with a ten-fold higher risk of PSC [75].”
Background
Cited by
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Hellmich, B., Sanchez-Alamo, B., Schirmer, J. H., Berti, A., Blockmans, D., Cid, M. C., Holle, J. U., Hollinger, N., Karadag, O., Kronbichler, A., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223764 · Cited by 768
Self-citationPonsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., Aabakken, L., Färkkilä, M., Petersen, B., Rupp, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.046 · Cited by 95
Metadata
- Authors
- Moiseev, S., Cohen Tervaert, J. W., Arimura, Y., Bogdanos, D. P., Csernok, E., Damoiseaux, J., Ferrante, M., Flores-Suárez, L. F., Fritzler, M. J., Invernizzi, P., Jayne, D., Jennette, J. C., Little, M. A., McAdoo, S. P., Novikov, P., Pusey, C. D., Radice, A., Salama, A. D., Savige, J. A., Segelmark, M., Shoenfeld, Y., Sinico, R. A., Sousa, M.-J., Specks, U., Terrier, B., Tzioufas, A. G., Vermeire, S., Zhao, M.-H., & Bossuyt, X.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 19
- Issue
- 9
- Pages
- 102618
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W3041655488
- Cited by
- 160
- References
- 7
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.